³ÉÈË¿ìÊÖ

Scotland’s daily PCR test capacity is over 66,000 per day. This is made up of a combination of the aggregate capacity of all testing sites/facilities and distribution/collection services where individuals can get a test, and laboratory capacity to process the samples taken.

As set out in our updated Testing Strategy, published on 22 June, testing is key to quickly identifying and isolating positive cases to break chains of transmission within a community. The testing system is designed to be completely flexible so neither sampling nor laboratory capacity is allocated to a specific local authority area. We work with Public Health Scotland to provide local decision makers with insights and data to target tests where they are most needed. We are also helping to maximise existing testing interventions at the request of local incident management teams (IMT). Local authorities’ testing response will vary as their approaches will be targeted to meet the needs of their communities.

Details of the daily number of tests carried out and number of positive cases in the Glasgow area are available from the Public Health Scotland dashboard.

Data on vaccination is compiled and forwarded to the Scottish Government by Public Health Scotland.

We do not hold data on vaccination rate for specific illnesses of conditions, but on how many people in a specific cohort have been vaccinated.

Latest vaccination figures can be found here : and

The UK Government announced that the UK would participate in the COVAX initiative in September 2020.

COVAX is a World Health Organisation (WHO) initiative to ensure that poorer countries have equitable access to COVID-19 tests, treatments and vaccines.

The initiative is designed to support the research, development and manufacturing of COVID-19 vaccines and negotiate their pricing.

On 8 June, UNICEF sent to G7 countries, urging them to donate 20% of their vaccines doses to COVAX by August.

To date the UK has committed over £500m to the Covax initiative, the UK has also announced it will donate at least 100 million surplus coronavirus vaccine doses within the next year, including 5 million beginning in the coming weeks.

In September 2020, the Scottish Government began a review of its approach to international development, and in December marked £2M of its International Development Fund (IDF) to support partner countries’ COVID-19 responses.

We remain on track to deliver the disability benefits to the timetable announced in November last year, starting with Child Disability Payment which will be piloted in summer this year and rolled out fully from the autumn.

Adult Disability Payment, our replacement for the UK Government’s Personal Independence Payment, will begin with a pilot for new applications in spring 2022 ahead of national launch by summer 2022.

This is of course subject to the continuing impact of the pandemic on our partners in delivery including in health and social care, local authorities, and the UK Government. We continue to work closely with colleagues in the Department for Work and Pensions to re-plan delivery of the remaining devolved benefits with this in mind.

In June 2017, Healthcare Improvement Scotland published their report on the Review of Ayrshire Maternity Unit, University Hospital Crosshouse, NHS Ayrshire & Arran (Adverse Events).

Recommendation seven said that NHS Scotland should develop and agree a list of mandatory skills and competencies for maternity services to support ongoing training programmes in NHS boards . NHS Education for Scotland facilitated a short life working group which identified a package of core mandatory update training for midwives and obstetricians. In December 2018 Scottish Government requested all NHS Boards ensure that midwives and obstetricians undertake the core mandatory update training required.

Due to the COVID-19 pandemic it has not been possible for staff to undertake face to face training, including elements of the package of core mandatory training, and staff time to undertake training has been significantly curtailed. Boards are actively looking at ways to take forward training in a COVID safe way, and many of the training packages have moved to virtual platforms to mitigate restrictions as a result of COVID.

As routine business is remobilised we expect Boards to move forward with completion of the package of Core Mandatory Training.

The Scottish Government holds monthly performance meetings with all NHS Boards, including NHS Grampian. Their last meeting was earlier this month.

Officials also hold weekly cancer performance meetings to monitor the Board’s progress with regards to cancer services.

Recovering the NHS is our immediate focus, and this is why we have committed to publishing an NHS Recovery Plan within the first 100 days.

As part of this, we are investing over £330 million in a network of National Treatment Centres, one of which will be located in NHS Grampian. This will provide additional capacity for elective care.

Travellers returning to Scotland from green and amber list countries must use the NHS tests, which can be booked through the UK Government’s booking portal for international travel. These kits are home test PCR kits provided by NHS Test & Trace.

NHS Scotland has no role in setting the price of the kits. The cost of the kits is set by the UK Government and the process managed through its contract with the travel management company, so our ability to reduce costs unilaterally is limited.

Everyone attending the Glasgow Fan Zone is encouraged to take a lateral flow test prior to the event. From Monday 14 June, rapid lateral flow test kits were mailed to 17,000 ticket holders due to attend the Glasgow Fan Zone, as part of a series of measures to help reduce the risk of transmission before and after the event.

A mobile testing bus has also been based at Glasgow Green to provide on-site lateral flow testing as an additional option for attendees. A selection of attendees have been asked by COVID marshals on site whether they have taken a test as part of ongoing reporting on the site.

These testing measures are in place in addition to other robust public health interventions, such as physical distancing, contact tracing, hand sanitiser stations, frequent cleaning, table-service, PPE for staff, and clear and informative signage.

The information requested can be found here: . Please note the figures provided for each local authority area do not differentiate between the different types of empty property.

If an individual has specific concerns arising from the results of a test they have taken, including related to their immunological response following vaccination, they should consult their primary clinician, who can determine whether further investigation is necessary.

The results of serology (antibody) tests, while indicative, may not be definitive. The value of antibody tests is currently limited to answering the question of whether someone has had COVID-19 before and providing data and a greater understanding on the spread of the virus. An antibody test cannot tell you if you’re immune to COVID-19 or whether you can or cannot spread the virus to other people.

Some individuals may not develop a serologically detectable antibody response to vaccination. Additionally, vaccination does not have an immediate protective effect, but takes up to 3 weeks to produce an antibody response. This is particularly true for elderly, immunocompromised, or infirm people.

In addition to the individual level of protection against severe disease or hospitalisation afforded by vaccination, an additional benefit of the vaccination programme is to assist in developing widespread community immunity and thereby reduce the force of transmission and viral reproduction rate, controlling the prevalence of COVID-19. The inoculation of a large proportion of the population will help to provide a degree of passive protection in the community for those who may develop a weaker immune response, although further research into the impact on transmission is underway. The majority of those inoculated with two doses of vaccine develop a high level of protection.

Further research is being conducted on the effect of the vaccination programme on transmission both in relation to current and new variants of concern. Until we know more, it is essential that everyone continues to follow public health guidance and the COVID-19 protection level rules which apply in their Local Authority area.